Systematic review of proinflammatory cytokines in obsessive-compulsive disorder

Current Psychiatry Reports

Volumn 14, Issue 3, 2012, Pages 220-228

  Gray, Simon M ^a   Bloch, Michael H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anxiety disorders; Cytokine; Depression; IL 1 ; IL 6; Interleukin; Meta analysis; Obsessive compulsive disorder; OCD; PANDAS; Proinflammatory; Review; TNF ; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

AGE DISTRIBUTION; COMORBIDITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEPRESSION; DISEASE ASSOCIATION; DRUG USE; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; OBSESSIVE COMPULSIVE DISORDER; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN FUNCTION; REVIEW; SYSTEMATIC REVIEW;

AGE FACTORS; ANTIPSYCHOTIC AGENTS; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; OBSESSIVE-COMPULSIVE DISORDER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84861098463     PISSN: 15233812     EISSN: 15351645     Source Type: Journal    
DOI: 10.1007/s11920-012-0272-0     Document Type: Review

References (62)

1. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR,Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593-602. (Pubitemid 40973434)
2. Ruscio AM, Stein DJ, Chiu WT, Kessler RC. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry. 2010;15:53-63.
3. DuPont RL, Rice DP, Shiraki S, Rowland CR. Economic costs of obsessive-compulsive disorder. Med Interface. 1995;8:102-9.
4. First MB. Diagnostic and statistical manual of mental disorders. 4th ed. Washington: American Psychiatric Association; 2000.
5. de Oliveira S, Pelajo C. Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infection (PANDAS): a controversial diagnosis. Curr Infect Dis Rep. 2010;12:103-9.
6. da Rocha FF, Correa H, Teixeira AL. Obsessive-compulsive disorder and immunology: a review. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:1139-46.
7. Swedo SE, Grant PJ. Annotation: PANDAS: a model for human autoimmune disease. J Child Psychol Psychiatry. 2005;46:227-34. (Pubitemid 40439428)
8. Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry. 1998;155:264-71. (Pubitemid 28074291)
9. Murphy TK, Kurlan R, Leckman J. The immunobiology of Tourette's disorder, pediatric autoimmune neuropsychiatric disorders associated with streptococcus, and related disorders: a way forward. J Child Adolesc Psychopharmacol. 2010;20:317-31.
10. Araki K, Turner AP, Shaffer VO, et al. mTOR regulates memory CD8 T-cell differentiation. Nature. 2009;460:108-12.
11. Shulman ST. Pediatric autoimmune neuropsychiatric disorders associated with streptococci (PANDAS): update. Curr Opin Pediatr. 2009;21:127.
12. Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67:446-57.
13. Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine. 1997;9:853-8. (Pubitemid 27494150)
14. Penninx BWJH, Kritchevsky SB, Yaffe K, et al. Inflammatory markers and depressed mood in older persons: results from the health, aging and body composition study. Biol Psychiatry. 2003;54:566-72. (Pubitemid 37289443)
15. Empana JP, Sykes DH, Luc G, et al. Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men. Circulation. 2005;111:2299-305.
16. Kim YK, Suh IB, Kim H, et al. The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs. Mol Psychiatry. 2002;7:1107.
17. Jones AL, Mowry BJ, Pender MP, Greer JM. Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis? Immunol Cell Biol. 2005;83:9-17. (Pubitemid 40179396)
18. Strous RD, Shoenfeld Y. Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited. J Autoimmun. 2006;27:71-80. (Pubitemid 44528264)
19. Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry. 2008;63:801-8. (Pubitemid 351410515)
20. Hannestad J, DellaGioia N, Bloch M. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology. 2011;36:2452-9.
21. Murphy K, Travers P, Walport M. Janeway's immunobiology. 7th ed. New York: Garland Science; 2008.
22. Steinke JW, Borish L. 3. Cytokines and chemokines. J Allergy Clin Immunol. 2006;117:S441-5.
23. Brough D, Tyrrell PJ, Allan SM. Regulation of interleukin-1 in acute brain injury. Trends Pharmacol Sci. 2011;32:617-22.
24. Konuk N, Tek, #x131, et al. Plasma levels of tumor necrosis factoralpha and interleukin-6 in obsessive compulsive disorder. Mediat Inflamm. 2007;2007.
25. Pan W, Zadina JE, Harlan RE, Weber JT, Banks WA, Kastin AJ. Tumor necrosis factor-alpha: a neuromodulator in the CNS. Neurosci Biobehav Rev. 1997;21:603-13. (Pubitemid 27458802)
26. Schöbitz B, de Kloet ER, Sutanto W, Holsboer F. Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Eur J Neurosci. 1993;5:1426-35. (Pubitemid 23325225)
27. Carlson NG, Wieggel WA, Chen J, Bacchi A, Rogers SW, Gahring LC. Inflammatory cytokines IL-1α, IL-1β, IL-6, and TNF-α impart neuroprotection to an excitotoxin through distinct pathways. J Immunol. 1999;163:3963-8. (Pubitemid 29450925)
28. Hirano T, Yasukawa K, Harada H, et al. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature. 1986;324:73-6. (Pubitemid 16008419)
29. Spooren A, Kolmus K, Laureys G, et al. Interleukin-6, a mental cytokine. Brain Res Rev. 2011;67:157-83.
30. Tadamitsu K. Interleukin-6 and its receptor in autoimmunity. J Autoimmun. 1992;5(Supplement A):123-32.
31. Xing Z, Gauldie J, Cox G, et al. IL-6 is an anti-inflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest. 1998;101:311-20. (Pubitemid 28067327)
32. Uyttenhove C, Coulie PG, Van Snick J. T cell growth and differentiation induced by interleukin-HP1/IL-6, the murine hybridoma/plasmacytoma growth factor. J Exp Med. 1988;167:1417-27.
33. Lotz M, Jirik F, Kabouridis P, et al. B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes. J Exp Med. 1988;167:1253-8.
34. Zheng H, Fletcher D, Kozak W, et al. Resistance to fever induction and impaired acute-phase response in interleukin-1β-deficient mice. Immunity. 1995;3:9-19.
35. Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood. 1994;83:113-8. (Pubitemid 24016522)
36. Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 2009;27:519-50.
37. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood. 1996;87:2095-147. (Pubitemid 26086851)
38. Marlin SD, Springer TA. Purified intercellular adhesion molecule- 1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell. 1987;51:813-9.
39. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol. 1986;137:245-54. (Pubitemid 16100296)
40. Sironi M, Breviario F, Proserpio P, et al. IL-1 stimulates IL-6 production in endothelial cells. J Immunol. 1989;142:549-53. (Pubitemid 19039975)
41. Wang CC, Fu CL, Yang YH, et al. Adenovirus expressing interleukin-1 receptor antagonist alleviates allergic airway inflammation in a murine model of asthma. Gene Ther. 2006;13:1414-21.
42. Nakae S, Asano M, Horai R, Iwakura Y. Interleukin-1β, but not interleukin-1α, is required for T-cell-dependent antibody production. Immunology. 2001;104:402-9. (Pubitemid 34037832)
43. Pfeffer K. Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth Factor Rev. 2003;14:185-91. (Pubitemid 36693140)
44. McCoy M, Tansey M. TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J Neuroinflamm. 2008;5:1-13.
45. Cairns CB, Panacek EA, Harken AH, Banerjee A. Bench to bedside tumor necrosis factor-alpha: from inflammation to resuscitation. Acad Emerg Med. 2000;7:930-41. (Pubitemid 30627528)
46. Graham AL, Allen JE, Read AF. Evolutionary causes and consequences of immunopathology. Annu Rev Ecol Evol Syst. 2005;36:373-97. (Pubitemid 43068863)
47. Deeks J, Higgins J, Altman D. Cochrane reviewer's handbook 4.2.2 [Updated March 2004] In: The Cochrane library. Chinchester: Wiley; 2004.
48. Brambilla F, Perna G, Bellodi L, et al. Plasma interleukin-1β and tumor necrosis factor concentrations in obsessive-compulsive disorders. Biol Psychiatry. 1997;42:976-81. (Pubitemid 27496427)
49. Maes M, Meltzer HY, Bosmans E. Psychoimmune investigation in obsessive-compulsive disorder: assays of plasma transferrin, IL-2 and IL-6 receptor, and IL-1β and IL-6 concentrations. Neuropsychobiology. 1994;30:57-60. (Pubitemid 24284802)
50. Monteleone P, Catapano F, Fabrazzo M, Tortorella A, Maj M. Decreased blood levels of tumor necrosis factor-alpha in patients with obsessive-compulsive disorder. Neuropsychobiology. 1998;37:182-5. (Pubitemid 28256877)
51. Leckman JF, Katsovich L, Kawikova I, et al. Increased serum levels of interleukin-12 and tumor necrosis factor-alpha in Tourette's syndrome. Biol Psychiatry. 2005;57:667-73. (Pubitemid 40409706)
52. Gabbay V, Coffey BJ, Guttman LE, et al. A cytokine study in children and adolescents with Tourette's disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:967-71.
53. Bos-Veneman NGP, Bijzet J, Limburg PC, Minderaa RB, Kallenberg CG, Hoekstra PJ. Cytokines and soluble adhesion molecules in children and adolescents with a tic disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34:1390-5.
54. Weizman R, Laor N, Barber Y, et al. Cytokine production in obsessive-compulsive disorder. Biol Psychiatry. 1996;40:908-12. (Pubitemid 26356726)
55. Denys D, Fluitman S, Kavelaars A, Heijnen C, Westenberg H. Decreased TNF-α and NK activity in obsessive-compulsive disorder. Psychoneuroendocrinology. 2004;29:945-52. (Pubitemid 38716121)
56. Denys D, Fluitman S, Kavelaars A, Heijnen C, Westenberg HGM. Effects of paroxetine and venlafaxine on immune parameters in patients with obsessive compulsive disorder. Psychoneuroendocrinology. 2006;31:355-60. (Pubitemid 43261655)
57. Fluitman S, Denys D, Vulink N, Schutters S, Heijnen C, Westenberg H. Lipopolysaccharide-induced cytokine production in obsessive-compulsive disorder and generalized social anxiety disorder. Psychiatry Res. 2010;178:313-6.
58. Fluitman SBAHA, Denys DAJP, Heijnen CJ, Westenberg HGM. Disgust affects TNF-alpha, IL-6 and noradrenalin levels in patients with obsessive-compulsive disorder. Psychoneuroendocrinology. 2010;35:906-11.
59. Carpenter LL, Heninger GR,McDougle CJ, Tyrka AR, Epperson CN, Price LH. Cerebrospinal fluid interleukin-6 in obsessive-compulsive disorder and trichotillomania. Psychiatry Res. 2002;112:257-62. (Pubitemid 35351727)
60. Mittleman BB, Castellanos FX, Jacobsen LK, Rapoport JL, Swedo SE, Shearer GM. Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease. J Immunol. 1997;159:2994-9. (Pubitemid 127681323)
61. Elenkov IJ, Chrousos GP. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci. 2002;966:290-303. (Pubitemid 34729188)
62. Vgontzas AN, Bixler EO, Lin HM, Prolo P, Trakada G, Chrousos GP. IL-6 and Its Circadian Secretion in Humans. Neuroimmunomodulation. 2005;12:131-40. (Pubitemid 40868672)